Safety and Liver Transduction Efficacy of rAAV5-cohPBGD in Nonhuman Primates: A Potential Therapy for Acute Intermittent Porphyria
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Liver Transduction Efficacy of rAAV5-cohPBGD in Nonhuman Primates: A Potential Therapy for Acute Intermittent Porphyria
Authors
Keywords
-
Journal
HUMAN GENE THERAPY
Volume 24, Issue 12, Pages 1007-1017
Publisher
Mary Ann Liebert Inc
Online
2013-09-27
DOI
10.1089/hum.2013.166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A largely random AAV integration profile after LPLD gene therapy
- (2013) Christine Kaeppel et al. NATURE MEDICINE
- Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
- (2013) Dwaipayan Sen et al. Scientific Reports
- Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver
- (2012) Ali Nowrouzi et al. MOLECULAR THERAPY
- Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transduction
- (2012) Ingo H. Pilz et al. VIROLOGY
- Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods
- (2012) Paolo Fagone et al. Human Gene Therapy Methods
- Immune Responses to AAV in Clinical Trials
- (2011) Federico Mingozzi et al. CURRENT GENE THERAPY
- Adeno-Associated Virus Liver Transduction Efficiency Measured by in Vivo [18F]FHBG Positron Emission Tomography Imaging in Rodents and Nonhuman Primates
- (2011) Astrid Pañeda et al. HUMAN GENE THERAPY
- Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis
- (2011) Joanna K. Dowman et al. LIVER TRANSPLANTATION
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
- (2011) Federico Mingozzi et al. NATURE REVIEWS GENETICS
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
- (2011) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analyzing the Number of Common Integration Sites of Viral Vectors – New Methods and Computer Programs
- (2011) Ulrich Abel et al. PLoS One
- Assessing the potential for AAV vector genotoxicity in a murine model
- (2010) H. Li et al. BLOOD
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice
- (2010) Carmen Unzu et al. MOLECULAR THERAPY
- Genome-wide high-throughput integrome analyses by nrLAM-PCR and next-generation sequencing
- (2010) Anna Paruzynski et al. Nature Protocols
- Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders
- (2009) Astrid Pañeda et al. HUMAN GENE THERAPY
- Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria
- (2009) Carmen Unzu et al. JOURNAL OF HEPATOLOGY
- Host and Vector-dependent Effects on the Risk of Germline Transmission of AAV Vectors
- (2009) Patricia Favaro et al. MOLECULAR THERAPY
- AAV8-mediated Gene Therapy Prevents Induced Biochemical Attacks of Acute Intermittent Porphyria and Improves Neuromotor Function
- (2009) Makiko Yasuda et al. MOLECULAR THERAPY
- Comprehensive genomic access to vector integration in clinical gene therapy
- (2009) Richard Gabriel et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation